| Previous Section | Index | Home Page |
5 Jun 2006 : Column 364W—continued
| Table 2. Doctor-diagnosed diabetes prevalence (observed and age-standardised) of adults( 1) , by Government office region and sex: 2003 England | |||||||||
| Percentages | |||||||||
| Government office region | |||||||||
| Doctor-diagnosed diabetes | North East | North West | Yorkshire and the Humber | East Midlands | West Midlands | East England | London | South East | South West |
| (1) Adults aged 16 and over. Source: Health Survey for England 2003 | |||||||||
Mr. Vara: To ask the Secretary of State for Health how many and what percentage of (a) adults and (b) children have Type 2 diabetes; and what the figures were in each year since 1997. [71385]
Ms Rosie Winterton: The Health Survey for England provides estimates of doctor-diagnosed diabetes. We are unable to provide figures of the percentage of children who have diabetes, as this information is not collected for children in the survey. However, we can provide the prevalence of adults with type 2 diabetes in England, in 2003, by sex. This data is shown in the following table. Data from previous Health Surveys' are not comparable to the 2003 data.
| Prevalence of doctor-diagnosed type 2 diabetes of adults( 1) , by sex, 2003, England | ||
| Number of doctor-diagnosed diabetes | Percentage of doctor-diagnosed diabetes | |
| (1) Adults aged 16 and over. Source: Health Survey for England 2003. | ||
John Bercow: To ask the Secretary of State for Health what recent discussions she has had with (a) physicians, (b) patients and (c) care groups about advances in diabetes care. [72049]
Ms Rosie Winterton: I met with Diabetes UK, the major charity in the United Kingdom working for people with diabetes, on 10 May 2006.
John Bercow: To ask the Secretary of State for Health what recent representations she has received on the merits of the use of insulin inhalers. [72050]
Ms Rosie Winterton: We have received a number of items of correspondence on inhaled insulin from the manufacturer of inhaled insulin, from Members of Parliament on behalf of their constituents, and from people with diabetes, their relatives and carers. The correspondence relates to the recent interim decision by the National Institute for Health and Clinical Excellence not to recommend inhaled insulin for the treatment of type 1 and type 2 diabetes, except in the context of clinical trials.
Drugs and Therapeutics Bulletin
Mr. Brady:
To ask the Secretary of State for Health what estimate she has made of the cost savings to the
NHS resulting from value for money recommendations contained in the Drug and Therapeutics Bulletin. [74474]
Andy Burnham: I have made no such assessment.
Mr. Brady: To ask the Secretary of State for Health what estimate she has made of the cost savings from ending her Department's funding of the Drug and Therapeutics Bulletin. [74475]
Andy Burnham: I refer the hon. Member to the reply given on 23 May 2006, Official Report, column 1743W.
Mr. Lansley: To ask the Secretary of State for Health what criteria the Department used in making the decision to withdraw central funds from the Drugs and Therapeutics Bulletin. [73230]
Andy Burnham: This decision was informed by our policy to devolve as much responsibility as possible to the national health service and to look very critically at central spending. It is our policy that central spending should be kept to an absolute minimum in order to maximise the resources available for the NHS to manage at local level. The decision also took account of the availability of other sources of medicines information.
Eating Disorders
David Simpson: To ask the Secretary of State for Health (1) how many and what percentage of people were estimated to have an eating disorder in each of the regions in each of the last three years; [69206]
(2) how many deaths in each of the regions have had eating disorders recorded as a contributory factor in each of the last five years. [69207]
Ms Rosie Winterton: The number and percentage of people estimated to have an eating disorder in each of the regions in England in each of the last three years is shown in Tables 1, 2 and 3. The data refer only to patients who were admitted to hospital and who had a primary diagnosis of eating disorder, but no data are available for patients with eating disorders who were not admitted to hospital.
Corroborative data are not available which attribute the cause of death wholly or partly to an eating disorder, and where there has also been admittance to hospital with a primary diagnosis of eating disorder. The cause of death in hospital may be unrelated to the primary diagnosis, which provides the main reason for a patient's admission only.
| Table 2: All diagnoses count of patients with eating disorders (ICD-10 F50) and as a percentage of the total population, NHS hospitals, 2003-04 | |||
| Government office region of residence | All diagnoses of patients with eating disorders admitted into NHS hospitals 2003-04 | Estimated population for 2003 | All diagnoses of patients with eating disorders admitted into NHS hospitals as a percentage of the total population 2003-04 |
| Next Section | Index | Home Page |